Dan Van Fleet represents borrowers and lenders as well as venture capital and private equity firms with respect to debt financings, with a focus on the technology and life sciences industries.

Dan draws on experience representing clients on all sides of debt financing transactions to deliver insightful counsel to borrowers, sponsors, and financial institutions. He has advised on billions of dollars’ worth of debt transactions, including:

  • Growth debt, including venture, structured, royalty, and lower middle market
  • Private capital, private equity, growth equity, and leveraged financings, including acquisitions, add-ons, and refinancings
  • Asset-based transactions, including IP-backed, recurring revenue, accounts receivable, inventory, and equipment financings
  • Structured equity and pre-IPO financings

Dan has served on the firm’s Training and Career Enhancement Committee and has received recognition from the firm as a best supervisor and a top supporter of recruiting and knowledge management efforts. He is an ally member of the firm’s Hispanic/Latin American Lawyers Group and sits on the firm’s Latin America Practice Leadership Team.

In law school, he was an editor on the Duke Law Journal and Duke Law & Technology Review.

He is a member of the Stanford and Duke Law alumni networks. Dan serves on Stanford’s Bing Overseas Study Program Advisory Council and the Duke Law Alumni Association Board of Directors.

Technology

Dan has advised on a variety of debt transactions in the technology industry, including those involving digital assets, cryptocurrency, Web3, cloud services, artificial intelligence (AI), and agtech, including:

  • Appodeal
  • Axios
  • Bright Machines
  • Canva
  • EasyPost
  • Examity
  • FUBOTV INC.
  • Inevitable Tech Inc
  • ironSource
  • Kandji
  • Nanosys
  • Owlet
  • Spot AI
  • Tarana Wireless

Life Sciences

Dan has advised on a variety of debt transactions in the healthcare and life sciences industries, including those involving medical device manufacturers, and pharmaceutical and biotech companies, including:

  • Alignment Healthcare
  • ATAI Life Sciences
  • BridgeBio
  • Centrexion
  • Coherus
  • Corium
  • Everly Health
  • KSQ Therapeutics
  • Neurelis
  • Phathom Pharmaceuticals
  • scPharmaceuticals
  • Sight Sciences

Venture Capital, Private Equity, Private Capital and Asset Managers

Dan regularly represents venture capital. private equity and other private capital firms in connection with private and public investments, acquisitions, and divestitures, including:

  • 8VC
  • Blue Owl Credit Advisors
  • Flagship Pioneering
  • Golub Capital
  • Hercules Capital
  • Kennedy Lewis Investment Management
  • Khosla Ventures
  • Marathon Capital 
  • North Haven Tactical Fund
  • Owl Rock Capital
  • SLR Investment Corp.
  • Trinity Capital Investments

Bar Qualification

  • California
  • New York

Education

  • JD, Duke University School of Law, 2009
    Duke Law Journal
  • LLM, Duke University, 2009
  • BA, Stanford University, 2005
    with honors